Prediction of Early Treatment Response to Initial Conventional Transarterial Chemoembolization Therapy for Hepatocellular Carcinoma by Machine-Learning Model Based on Computed Tomography

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Villanueva A. Hepatocellular Carcinoma. N Engl J Med. 2019;380(15):1450–1462. doi:10.1056/NEJMra1713263
   PubMed Web of Science ®Google Scholar
• Bruix J, Reig M, Sherman M. Evidence-based diagnosis staging, and treatment of patients with Hepatocellular carcinoma. Gastroenterology. 2016;150(4):835–853. doi:10.1053/j.gastro.2015.12.041
   PubMed Web of Science ®Google Scholar
• Sangro B, Salem R. Transarterial chemoembolization and radioembolization. Semin Liver Dis. 2014;34(4):435–443. doi:10.1055/s-0034-1394142
   PubMed Web of Science ®Google Scholar
• Wang JH, Zhong XP, Zhang YF, et al. Cezanne predicts progression and adjuvant TACE response in hepatocellular carcinoma. Cell Death Dis. 2017;8:8.
   Web of Science ®Google Scholar
• Arizumi T, Ueshima K, Minami T, et al. Effectiveness of sorafenib in patients with Transcatheter Arterial Chemoembolization (TACE) refractory and intermediate-stage Hepatocellular Carcinoma. Liver Cancer. 2015;4(4):253–262. doi:10.1159/000367743
   PubMed Web of Science ®Google Scholar
• Cappelli A, Cucchetti A, Cabibbo G, et al. Refining prognosis after trans-arterial chemo-embolization for hepatocellular carcinoma. Liver Int. 2016;36(5):729–736. doi:10.1111/liv.13029
   PubMed Web of Science ®Google Scholar
• Chen MY, Cao JS, Hu JH, et al. Clinical-radiomic analysis for pretreatment prediction of objective response to first transarterial chemoembolization in hepatocellular carcinoma. Liver Cancer. 2021;10(1):38–51. doi:10.1159/000512028
   PubMed Web of Science ®Google Scholar
• Kong C, Zhao Z, Chen W, et al. Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE. Eur Radiol. 2021;16:1–2.
   Google Scholar
• Zhao Y, Wang N, Wu JJ, et al. Radiomics analysis based on contrast-enhanced MRI for prediction of therapeutic response to transarterial chemoembolization in Hepatocellular Carcinoma. Front Oncol. 2021;11:12.
   Web of Science ®Google Scholar
• Zhang L, Xia W, Yan ZP, et al. Deep learning predicts overall survival of patients with unresectable hepatocellular carcinoma treated by transarterial chemoembolization plus sorafenib. Front Oncol. 2020;10:11.
   Web of Science ®Google Scholar
• Kawakami E, Tabata J, Yanaihara N, et al. Application of artificial intelligence for preoperative diagnostic and prognostic prediction in epithelial ovarian cancer based on blood biomarkers. Clin Cancer Res. 2019;25(10):3006–3015. doi:10.1158/1078-0432.CCR-18-3378
   PubMed Web of Science ®Google Scholar
• Wang Y, Ji CP, Wang Y, et al. Predicting postoperative liver cancer death outcomes with machine learning. Curr Med Res Opin. 2021;37(4):629–634. doi:10.1080/03007995.2021.1885361
   PubMed Web of Science ®Google Scholar
• Shi J, Lai ECH, Li N, et al. A new classification for hepatocellular carcinoma with portal vein tumor thrombus. J Hepato-Biliary-Pancreat Sci. 2011;18(1):74–80. doi:10.1007/s00534-010-0314-0
   PubMed Web of Science ®Google Scholar
• Cheng SQ, Wu MC, Chen H, et al. Tumor thrombus types influence the prognosis of hepatocellular carcinoma with the tumor thrombi in the portal vein. Hepato-Gastroenterol. 2007;54(74):499–502.
   Google Scholar
• Cheng SQ, Chen MS, Cai JQ, et al. Chinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus (2018 Edition). Liver Cancer. 2020;9(1):28–40. doi:10.1159/000503685
   PubMed Web of Science ®Google Scholar
• Lencioni R, Montal R, Torre F, et al. Objective response by mRECIST as a predictor and potential surrogate end-point of overall survival in advanced HCC. J Hepatol. 2017;66(6):1166–1172. doi:10.1016/j.jhep.2017.01.012
   PubMed Web of Science ®Google Scholar
• Meng XP, Wang YC, Ju SH, et al. Radiomics analysis on multiphase contrast-enhanced CT: a survival prediction tool in patients with hepatocellular carcinoma undergoing transarterial chemoembolization. Front Oncol. 2020;10:12. doi:10.3389/fonc.2020.01196
   Web of Science ®Google Scholar
• Zhong BY, Yan ZP, Sun JH, et al. Random survival forests to predict disease control for Hepatocellular carcinoma treated with transarterial chemoembolization combined with sorafenib. Front Mol Biosci. 2021;20:8.
   Google Scholar
• Seo H, Khuzani MB, Vasudevan V, et al. Machine learning techniques for biomedical image segmentation: an overview of technical aspects and introduction to state-of-art applications. Med Phys. 2020;47(5):E148–E167. doi:10.1002/mp.13649
   PubMed Web of Science ®Google Scholar
• Lv WF, Liu KC, Lu D, et al. Transarterial chemoembolization for hepatocellular carcinoma combined with portal vein tumor thrombosis. Cancer Manag Res. 2018;10:4719–4726. doi:10.2147/CMAR.S166527
   PubMed Web of Science ®Google Scholar
• Yu SJ, Kim YJ. Effective treatment strategies other than sorafenib for the patients with advanced hepatocellular carcinoma invading portal vein. World J Hepatol. 2015;7(11):1553–1561. doi:10.4254/wjh.v7.i11.1553
   PubMed Web of Science ®Google Scholar
• Niu ZJ, Ma YL, Kang P, et al. Transarterial chemoembolization compared with conservative treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus: using a new classification. Med Oncol. 2012;29(4):2992–2997. doi:10.1007/s12032-011-0145-0
   PubMed Web of Science ®Google Scholar
• Sun YJ, Bai HL, Xia W, et al. Predicting the outcome of transcatheter arterial embolization therapy for unresectable Hepatocellular carcinoma based on radiomics of preoperative multiparameter MRI. J Magn Reson Imaging. 2020;52(4):1083–1090. doi:10.1002/jmri.27143
   Web of Science ®Google Scholar
• Morshid A, Elsayes KM, Khalaf AM, et al. A machine learning model to predict hepatocellular carcinoma response to transcatheter arterial chemoembolization. Radiol Artif Intell. 2019;1:5. doi:10.1148/ryai.2019180021
   Google Scholar
• Lee S, Kim SH, Lee JE, et al. Preoperative gadoxetic acid-enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma. J Hepatol. 2017;67(3):526–534. doi:10.1016/j.jhep.2017.04.024
   PubMed Web of Science ®Google Scholar
• An C, Kim DW, Park YN, et al. Single Hepatocellular Carcinoma: preoperative MR imaging to predict early recurrence after curative resection. Radiology. 2015;276(2):433–443. doi:10.1148/radiol.15142394
   PubMed Web of Science ®Google Scholar
• Choi WS, Chang W, Lee M, et al. Spectral CT-based iodized oil quantification to predict tumor response following chemoembolization of Hepatocellular carcinoma. J Vasc Interv Radiol. 2021;32(1):16–22. doi:10.1016/j.jvir.2020.09.020
   Web of Science ®Google Scholar